Abstract
Breakthroughs in understanding the epigenetic mechanisms involved in neurodegenerative disease have highlighted “epidrugs” as a potential avenue for therapeutic development. Here, we expand on the future of epidrugs against neurodegeneration and discuss promising novel targets underexploited thus far: histone kinases.
Funding Information
  • Research Foundation of The City University of New York
  • Brooklyn College

This publication has 38 references indexed in Scilit: